$WEAV

Weave Communications Q2 Earnings Call Highlights

Weave Communications (NYSE:WEAV) reported Q2 expense ratios and ended the quarter with $78.5M cash and short-term investments. It generated $10.2M operating cash flow and $8.7M free cash flow, with positive FCF in H1 2026. The company reorganized its go-to-market model, causing May-July booking shortfalls. Full-year revenue guidance is $273M-$275M and non-GAAP operating income $12M-$14M.

Original reporting
Published Aug 9, 2026, 5:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 5:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Weave Communications Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$WEAVNeutralMed
01

Why it matters

Management raised full-year non-GAAP operating-income guidance to $12M-$14M and provided Q3 revenue and operating-income ranges, while attributing slightly below-expected bookings to lead-distribution calibration during May-July.

02

Market read

Traders can update near-term revenue expectations around the SDR transition timing and weigh it against improved operating-efficiency guidance and accelerating AI engagement metrics.

03

What to watch

The article emphasizes AI feature growth and athenahealth integration depth, which could support retention and ARPA, partially offsetting the revenue timing dip.

Relevance 8/10Novelty 7/10Timing: post-Q2 call, sets full-year and Q3 revenue and operating-income ranges

Background

Weave reported Q2 expense and cash metrics and discussed a go-to-market reorganization shifting inbound verticalized sellers and outbound prospecting to an SDR model.

Company-level read

Ticker impact

$WEAVNeutralMedium confidence
Context

Weave guided full-year revenue to $273M-$275M and Q3 revenue to $68.6M-$69.6M after a go-to-market reorg disrupted bookings.

Expected impact

Likely choppy reaction risk: upside from raised non-GAAP operating-income outlook, offset by revenue timing pressure from bookings slightly below expectation.

Evidence & confidence

The article provides specific forward revenue and operating-income ranges plus a causal explanation (May-July adjustment period) that can affect near-term estimates and revisions.

Market effects

Highlights execution risk and monetization mechanics for AI-enabled healthcare communications and payments platforms.

No clear regional spillover beyond US-listed small-cap tech/health IT sentiment.

Limited global relevance; primarily impacts healthcare SMB communications and practice-management software expectations.

Counterpoint

If the SDR transition is now completed (first week of August), the near-term bookings shortfall may be less persistent than investors fear.

Key entities

  • Weave Communications

    AI-powered patient engagement and payments platform for healthcare practices, NYSE-listed as WEAV.

  • athenahealth

    Integration partner; Weave expanded its athenaOne integration and joined the athenahealth Marketplace during the quarter.

Related articles

$WEAVMed

Weave Communications, Inc. (WEAV): Results of Operations and Financial Condition

Weave Communications, Inc. (WEAV) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a991-weaveearningsreleasex.htm EX-99.1 Document Weave Announces Second Quarter 2026 Financial Results • Second quarter total revenue of $67.5 million, up 15.5% year over year • Second quarter GAAP gross margin of 72.0%, up 30 basis points year over year • Second quarter

$AHCOHighAI 9/10

Why AdaptHealth Stock Plummeted This Week

AdaptHealth (NASDAQ: AHCO) shares fell about 47% this week after the company reported Q2 results below expectations and issued sharply lower guidance. Analysts expected EPS of $0.15; AdaptHealth posted a loss of $1.07 per share. Sales rose 12.7% to $740.3M but missed forecasts. Full-year sales guidance was cut to $2.85B-$2.89B and EBITDA and FCF ranges were reduced.

$WMSMed

Advanced Drainage Systems Q1 Earnings Call Highlights

Advanced Drainage Systems (NYSE:WMS) reported Q1 growth in stormwater storage, with the stormwater storage category up 18% and residential sales up 29% (primarily NDS). Management said NDS contributed $95 million in quarterly sales. The company maintained FY2027 outlook: net sales $3.35B to $3.55B and adjusted EBITDA $1.0B to $1.05B, with Q2 margin expected to decline.

$WPPMed

WPP H1 Earnings Call Highlights

WPP plc (NYSE:WPP) reported H1 headline operating profit of £398m (8.4% margin) and said headline diluted EPS fell to £0.151 from £0.20. Net debt was £2.9bn. The board declared an interim dividend of £0.075/share. For 2H, WPP expects like-for-like revenue less pass-through costs to decline low to mid-single digits and keeps 12% to 13% margin guidance.

$WTSMedAI 8/10

Watts Water Technologies Q2 Earnings Call Highlights

Watts Water Technologies (NYSE:WTS) raised its data center served addressable market estimate to about $2 billion from over $1 billion, citing broader global demand and liquid-cooling adoption. Q2 adjusted EBITDA rose 15% to $177 million. Watts lifted full-year organic sales growth to 8% to 11% and reported sales to 14% to 17%.

$WRBYMedAI 8/10

Warby Parker Q2 Earnings Call Highlights

Warby Parker (NYSE:WRBY) reported Q2 retail revenue up 13.6% YoY, with eye exams growing over 30% YoY to about 7% of revenue. E-commerce revenue was $58.7M, down 0.3% YoY. The company reaffirmed FY revenue guidance of $959M to $976M and adjusted EBITDA of $117M to $119M, excluding Intelligent Eyewear.